Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Charles Duncan is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 02/27/2025 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 64.37% | Charles Duncan72% | $28 → $28 | Reiterates | Overweight → Overweight | Get Alert |
| 02/26/2025 | JAZZ | Buy Now | Jazz Pharmaceuticals | $134.28 | 11.7% | Charles Duncan72% | $140 → $150 | Downgrade | Overweight → Neutral | Get Alert |
| 02/19/2025 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | 26.21% | Charles Duncan72% | $153 → $153 | Reiterates | Overweight → Overweight | Get Alert |
| 02/13/2025 | GHRS | Buy Now | GH Research | $12.88 | 8.7% | Charles Duncan72% | → $14 | Initiates | → Overweight | Get Alert |
| 01/10/2025 | DRUG | Buy Now | Bright Minds Biosciences | $36.90 | — | Charles Duncan72% | — | Initiates | → Overweight | Get Alert |
| 12/17/2024 | BHVN | Buy Now | Biohaven | $29.88 | — | Charles Duncan72% | — | Reiterates | Overweight → Overweight | Get Alert |
| 12/12/2024 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | -0.19% | Charles Duncan72% | $121 → $121 | Reiterates | Overweight → Overweight | Get Alert |
| 12/10/2024 | STOK | Buy Now | Stoke Therapeutics | $8.26 | — | Charles Duncan72% | — | Reiterates | Overweight → Overweight | Get Alert |
| 11/14/2024 | MRNS | Buy Now | Marinus Pharma | — | — | Charles Duncan72% | $4 → $4 | Reiterates | Overweight → Overweight | Get Alert |
| 10/30/2024 | HRMY | Buy Now | Harmony Biosciences | $33.78 | 71.7% | Charles Duncan72% | $51 → $58 | Maintains | Overweight | Get Alert |
| 10/25/2024 | MRNS | Buy Now | Marinus Pharma | — | — | Charles Duncan72% | $13 → $4 | Maintains | Overweight | Get Alert |
| 10/25/2024 | ALKS | Buy Now | Alkermes | $34.22 | 25.66% | Charles Duncan72% | $48 → $43 | Maintains | Overweight | Get Alert |
| 10/23/2024 | BHVN | Buy Now | Biohaven | $29.88 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 10/18/2024 | CYTK | Buy Now | Cytokinetics | $44.01 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 10/10/2024 | ALKS | Buy Now | Alkermes | $34.22 | 40.27% | Charles Duncan72% | $48 → $48 | Reiterates | Overweight → Overweight | Get Alert |
| 10/04/2024 | BHVN | Buy Now | Biohaven | $29.88 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 09/30/2024 | PRTA | Buy Now | Prothena Corp | $12.99 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 09/24/2024 | MRNS | Buy Now | Marinus Pharma | — | — | Charles Duncan72% | $13 → $13 | Reiterates | Overweight → Overweight | Get Alert |
| 09/24/2024 | BHVN | Buy Now | Biohaven | $29.88 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 09/20/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $131.71 | -1.29% | Charles Duncan72% | $130 → $130 | Reiterates | Overweight → Overweight | Get Alert |
| 09/20/2024 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | -11.74% | Charles Duncan72% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/16/2024 | NBIX | Buy Now | Neurocrine Biosciences | $115.10 | 34.67% | Charles Duncan72% | $155 → $155 | Reiterates | Overweight → Overweight | Get Alert |
| 09/16/2024 | MRNS | Buy Now | Marinus Pharma | — | — | Charles Duncan72% | $13 → $13 | Reiterates | Overweight → Overweight | Get Alert |
| 09/16/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $131.71 | -1.29% | Charles Duncan72% | $130 → $130 | Reiterates | Overweight → Overweight | Get Alert |
| 09/16/2024 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | -11.74% | Charles Duncan72% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/16/2024 | ALKS | Buy Now | Alkermes | $34.22 | 40.27% | Charles Duncan72% | $48 → $48 | Reiterates | Overweight → Overweight | Get Alert |
| 09/09/2024 | KALV | Buy Now | KalVista Pharma | $12.21 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 09/09/2024 | CYTK | Buy Now | Cytokinetics | $44.01 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 09/09/2024 | CMPS | Buy Now | Compass Pathways | $2.97 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 09/09/2024 | MRNS | Buy Now | Marinus Pharma | — | — | Charles Duncan72% | $13 → $13 | Reiterates | Overweight → Overweight | Get Alert |
| 09/09/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $134.28 | 4.26% | Charles Duncan72% | $140 → $140 | Reiterates | Overweight → Overweight | Get Alert |
| 09/09/2024 | DNLI | Buy Now | Denali Therapeutics | $14.32 | 144.41% | Charles Duncan72% | $35 → $35 | Reiterates | Overweight → Overweight | Get Alert |
| 09/09/2024 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | -11.74% | Charles Duncan72% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/06/2024 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | -11.74% | Charles Duncan72% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/06/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $131.71 | -30.15% | Charles Duncan72% | $68 → $92 | Upgrade | Neutral → Overweight | Get Alert |
| 08/29/2024 | NBIX | Buy Now | Neurocrine Biosciences | $115.10 | 34.67% | Charles Duncan72% | $170 → $155 | Maintains | Overweight | Get Alert |
| 08/19/2024 | BHVN | Buy Now | Biohaven | $29.88 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 08/12/2024 | PRTA | Buy Now | Prothena Corp | $12.99 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 08/12/2024 | BHVN | Buy Now | Biohaven | $29.88 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 08/08/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $131.71 | -1.29% | Charles Duncan72% | $120 → $130 | Maintains | Overweight | Get Alert |
| 08/07/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 64.37% | Charles Duncan72% | $37 → $28 | Maintains | Overweight | Get Alert |
| 08/01/2024 | VNDA | Buy Now | Vanda Pharma | $4.78 | 172.25% | Charles Duncan72% | $11 → $13 | Maintains | Overweight | Get Alert |
| 08/01/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $134.28 | 4.26% | Charles Duncan72% | $140 → $140 | Reiterates | Overweight → Overweight | Get Alert |
| 07/31/2024 | CYBN | Buy Now | Cybin | $7.16 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 07/30/2024 | CGTX | Buy Now | Cognition Therapeutics | $0.45 | — | Charles Duncan72% | — | Downgrade | Overweight → Neutral | Get Alert |
| 07/26/2024 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | -11.74% | Charles Duncan72% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 07/25/2024 | NBIX | Buy Now | Neurocrine Biosciences | $115.10 | 34.67% | Charles Duncan72% | $155 → $155 | Reiterates | Overweight → Overweight | Get Alert |
| 07/25/2024 | ALKS | Buy Now | Alkermes | $34.22 | 40.27% | Charles Duncan72% | $48 → $48 | Reiterates | Overweight → Overweight | Get Alert |
| 07/11/2024 | VNDA | Buy Now | Vanda Pharma | $4.78 | 130.37% | Charles Duncan72% | → $11 | Initiates | → Overweight | Get Alert |
| 06/21/2024 | MNMD | Buy Now | Mind Medicine | $6.75 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 06/21/2024 | CYBN | Buy Now | Cybin | $7.16 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 06/21/2024 | CMPS | Buy Now | Compass Pathways | $2.97 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 06/21/2024 | ATAI | Buy Now | ATAI Life Sciences | $1.66 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 06/14/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $131.71 | -8.89% | Charles Duncan72% | $120 → $120 | Reiterates | Overweight → Overweight | Get Alert |
| 05/30/2024 | BHVN | Buy Now | Biohaven | $29.88 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 05/23/2024 | ALKS | Buy Now | Alkermes | $34.22 | 40.27% | Charles Duncan72% | $43 → $48 | Maintains | Overweight | Get Alert |
| 05/09/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 117.2% | Charles Duncan72% | $37 → $37 | Reiterates | Overweight → Overweight | Get Alert |
| 04/30/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 117.2% | Charles Duncan72% | $37 → $37 | Reiterates | Overweight → Overweight | Get Alert |
| 04/30/2024 | CMPS | Buy Now | Compass Pathways | $2.97 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 04/24/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $131.71 | -8.89% | Charles Duncan72% | $120 → $120 | Reiterates | Overweight → Overweight | Get Alert |
| 04/19/2024 | CMPS | Buy Now | Compass Pathways | $2.97 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 04/18/2024 | CMPS | Buy Now | Compass Pathways | $2.97 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 04/18/2024 | BHVN | Buy Now | Biohaven | $29.88 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 04/12/2024 | HRMY | Buy Now | Harmony Biosciences | $33.78 | 45.06% | Charles Duncan72% | $49 → $49 | Reiterates | Overweight → Overweight | Get Alert |
| 04/10/2024 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | -11.74% | Charles Duncan72% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 04/10/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 117.2% | Charles Duncan72% | $37 → $37 | Reiterates | Overweight → Overweight | Get Alert |
| 04/10/2024 | MRNS | Buy Now | Marinus Pharma | — | — | Charles Duncan72% | $28 → $28 | Reiterates | Overweight → Overweight | Get Alert |
| 04/10/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $134.28 | 34.04% | Charles Duncan72% | $180 → $180 | Reiterates | Overweight → Overweight | Get Alert |
| 04/10/2024 | BHVN | Buy Now | Biohaven | $29.88 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 04/10/2024 | PRTA | Buy Now | Prothena Corp | $12.99 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 04/10/2024 | NBIX | Buy Now | Neurocrine Biosciences | $115.10 | 34.67% | Charles Duncan72% | → $155 | Reiterates | Overweight → Overweight | Get Alert |
| 04/04/2024 | ATAI | Buy Now | ATAI Life Sciences | $1.66 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 04/04/2024 | STOK | Buy Now | Stoke Therapeutics | $8.26 | — | Charles Duncan72% | — | Reiterates | → Overweight | Get Alert |
| 03/28/2024 | HRMY | Buy Now | Harmony Biosciences | $33.78 | 45.06% | Charles Duncan72% | $49 → $49 | Reiterates | Overweight → Overweight | Get Alert |
| 03/22/2024 | CPRX | Buy Now | Catalyst Pharmaceuticals | $25.50 | 33.31% | Charles Duncan72% | $34 → $34 | Reiterates | Overweight → Overweight | Get Alert |
| 03/22/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $134.28 | 34.04% | Charles Duncan72% | $180 → $180 | Reiterates | Overweight → Overweight | Get Alert |
| 03/14/2024 | CPRX | Buy Now | Catalyst Pharmaceuticals | $25.50 | 33.31% | Charles Duncan72% | $34 → $34 | Reiterates | Overweight → Overweight | Get Alert |
| 03/12/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 117.2% | Charles Duncan72% | $42 → $37 | Maintains | Overweight | Get Alert |
| 03/01/2024 | CPRX | Buy Now | Catalyst Pharmaceuticals | $25.50 | 33.31% | Charles Duncan72% | $27 → $34 | Maintains | Overweight | Get Alert |
| 02/29/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $134.28 | 34.04% | Charles Duncan72% | $180 → $180 | Reiterates | Overweight → Overweight | Get Alert |
| 02/28/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 146.55% | Charles Duncan72% | $42 → $42 | Reiterates | Overweight → Overweight | Get Alert |
| 02/23/2024 | HRMY | Buy Now | Harmony Biosciences | $33.78 | 45.06% | Charles Duncan72% | $49 → $49 | Reiterates | Overweight → Overweight | Get Alert |
| 02/23/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $131.71 | -23.31% | Charles Duncan72% | $101 → $101 | Reiterates | Overweight → Overweight | Get Alert |
| 02/21/2024 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | -15.04% | Charles Duncan72% | $108 → $103 | Maintains | Overweight | Get Alert |
| 02/20/2024 | KRTX | Buy Now | Karuna Therapeutics | — | — | Charles Duncan72% | $330 → $330 | Reiterates | Neutral → Neutral | Get Alert |
| 02/20/2024 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | -10.91% | Charles Duncan72% | → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 02/02/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 146.55% | Charles Duncan72% | $42 → $42 | Reiterates | Overweight → Overweight | Get Alert |
| 01/22/2024 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | -10.91% | Charles Duncan72% | $108 → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 01/17/2024 | KRTX | Buy Now | Karuna Therapeutics | — | — | Charles Duncan72% | $330 → $330 | Reiterates | Neutral → Neutral | Get Alert |
| 01/09/2024 | PRTA | Buy Now | Prothena Corp | $12.99 | 569.75% | Charles Duncan72% | $129 → $87 | Maintains | Overweight | Get Alert |
| 12/20/2023 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | -10.91% | Charles Duncan72% | $108 → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 12/18/2023 | PRTA | Buy Now | Prothena Corp | $12.99 | 893.07% | Charles Duncan72% | $129 → $129 | Reiterates | Overweight → Overweight | Get Alert |
| 12/14/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 146.55% | Charles Duncan72% | $42 → $42 | Reiterates | Overweight → Overweight | Get Alert |
| 12/14/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $131.71 | -23.31% | Charles Duncan72% | $101 → $101 | Reiterates | Overweight → Overweight | Get Alert |
| 12/07/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Charles Duncan72% | $38 → $45 | Downgrade | Overweight → Neutral | Get Alert |
| 11/07/2023 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | -10.91% | Charles Duncan72% | → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 11/03/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $131.71 | -23.31% | Charles Duncan72% | $98 → $101 | Maintains | Overweight | Get Alert |
| 10/24/2023 | DNLI | Buy Now | Denali Therapeutics | $14.32 | 144.41% | Charles Duncan72% | $85 → $35 | Assumes | → Overweight | Get Alert |
| 10/24/2023 | CRNX | Buy Now | Crinetics Pharmaceuticals | $34.84 | 43.53% | Charles Duncan72% | $52 → $50 | Assumes | → Overweight | Get Alert |
| 10/24/2023 | NBIX | Buy Now | Neurocrine Biosciences | $115.10 | — | Charles Duncan72% | — | Assumes | → Overweight | Get Alert |
| 10/23/2023 | PRTA | Buy Now | Prothena Corp | $12.99 | 893.07% | Charles Duncan72% | → $129 | Reiterates | Overweight → Overweight | Get Alert |
| 10/09/2023 | CYTK | Buy Now | Cytokinetics | $44.01 | 47.69% | Charles Duncan72% | $59 → $65 | Maintains | Overweight | Get Alert |
| 09/22/2023 | SLDB | Buy Now | Solid Biosciences | $4.55 | 9.89% | Charles Duncan72% | → $5 | Initiates | → Overweight | Get Alert |
| 09/21/2023 | MRNS | Buy Now | Marinus Pharma | — | — | Charles Duncan72% | → $28 | Reiterates | Overweight → Overweight | Get Alert |
| 09/21/2023 | SEEL | Buy Now | Seelos Therapeutics | $0.39 | — | Charles Duncan72% | — | Downgrade | Overweight → Neutral | Get Alert |
| 09/13/2023 | NBIX | Buy Now | Neurocrine Biosciences | $115.10 | 18.16% | Charles Duncan72% | → $136 | Reiterates | Overweight → Overweight | Get Alert |
| 09/07/2023 | VXRT | Buy Now | Vaxart | $0.49 | 713.34% | Charles Duncan72% | → $4 | Reiterates | Overweight → Overweight | Get Alert |
| 08/31/2023 | DNLI | Buy Now | Denali Therapeutics | $14.32 | 493.58% | Charles Duncan72% | → $85 | Reiterates | Overweight → Overweight | Get Alert |
| 08/29/2023 | CYBN | Buy Now | Cybin | $7.16 | -58.1% | Charles Duncan72% | → $114 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | LUCD | Buy Now | Lucid Diagnostics | $1.52 | 163.16% | Charles Duncan72% | → $4 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | XENE | Buy Now | Xenon Pharmaceuticals | $34.77 | 66.81% | Charles Duncan72% | → $58 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | SEEL | Buy Now | Seelos Therapeutics | $0.39 | 412.82% | Charles Duncan72% | → $7680 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | PRTA | Buy Now | Prothena Corp | $12.99 | 893.07% | Charles Duncan72% | → $129 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | NBIX | Buy Now | Neurocrine Biosciences | $115.10 | 18.16% | Charles Duncan72% | → $136 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | MNMD | Buy Now | Mind Medicine | $6.75 | 3.78% | Charles Duncan72% | → $7 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | LUMO | Buy Now | Lumos Pharma | — | — | Charles Duncan72% | → $10 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | Charles Duncan72% | → $214 | Reiterates | Neutral → Neutral | Get Alert |
| 08/22/2023 | KALV | Buy Now | KalVista Pharma | $12.21 | 63.8% | Charles Duncan72% | → $20 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $131.71 | -25.59% | Charles Duncan72% | → $98 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | HRMY | Buy Now | Harmony Biosciences | $33.78 | 122.02% | Charles Duncan72% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | DNLI | Buy Now | Denali Therapeutics | $14.32 | 493.58% | Charles Duncan72% | → $85 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | CYTK | Buy Now | Cytokinetics | $44.01 | 34.06% | Charles Duncan72% | → $59 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | CYBN | Buy Now | Cybin | $7.16 | -58.1% | Charles Duncan72% | → $114 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | CRNX | Buy Now | Crinetics Pharmaceuticals | $34.84 | 29.18% | Charles Duncan72% | → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | CPRX | Buy Now | Catalyst Pharmaceuticals | $25.50 | 5.86% | Charles Duncan72% | → $27 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | BIVI | Buy Now | BioVie | $1.11 | 890.99% | Charles Duncan72% | → $110 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | -10.91% | Charles Duncan72% | → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 08/16/2023 | LUCD | Buy Now | Lucid Diagnostics | $1.52 | 163.16% | Charles Duncan72% | → $4 | Reiterates | Overweight → Overweight | Get Alert |
| 08/16/2023 | CLNN | Buy Now | Clene | $3.62 | 10.5% | Charles Duncan72% | → $80 | Reiterates | Overweight → Overweight | Get Alert |
| 08/15/2023 | SEEL | Buy Now | Seelos Therapeutics | $0.39 | 412.82% | Charles Duncan72% | → $7680 | Reiterates | Overweight → Overweight | Get Alert |
| 08/15/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Charles Duncan72% | → $172 | Reiterates | Neutral → Neutral | Get Alert |
| 08/15/2023 | LUMO | Buy Now | Lumos Pharma | — | — | Charles Duncan72% | $14 → $10 | Maintains | Overweight | Get Alert |
| 08/14/2023 | CRDL | Buy Now | Cardiol Therapeutics | $1.16 | 158.62% | Charles Duncan72% | → $3 | Reiterates | Overweight → Overweight | Get Alert |
| 08/11/2023 | CPRX | Buy Now | Catalyst Pharmaceuticals | $25.50 | 5.86% | Charles Duncan72% | $25 → $27 | Maintains | Overweight | Get Alert |
| 08/10/2023 | DNLI | Buy Now | Denali Therapeutics | $14.32 | 493.58% | Charles Duncan72% | → $85 | Reiterates | Overweight → Overweight | Get Alert |
| 08/08/2023 | STOK | Buy Now | Stoke Therapeutics | $8.26 | 69.49% | Charles Duncan72% | $18 → $14 | Maintains | Overweight | Get Alert |
| 08/07/2023 | VXRT | Buy Now | Vaxart | $0.49 | 713.34% | Charles Duncan72% | $6 → $4 | Maintains | Overweight | Get Alert |
| 07/24/2023 | LUMO | Buy Now | Lumos Pharma | — | — | Charles Duncan72% | → $14 | Reiterates | Overweight → Overweight | Get Alert |
| 07/24/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Charles Duncan72% | $110 → $145 | Maintains | Overweight | Get Alert |
| 07/18/2023 | PRTA | Buy Now | Prothena Corp | $12.99 | 893.07% | Charles Duncan72% | → $129 | Reiterates | Overweight → Overweight | Get Alert |
| 07/18/2023 | BIVI | Buy Now | BioVie | $1.11 | 890.99% | Charles Duncan72% | → $110 | Reiterates | Overweight → Overweight | Get Alert |
| 07/17/2023 | BHVN | Buy Now | Biohaven | $29.88 | 3.75% | Charles Duncan72% | → $31 | Reiterates | Overweight → Overweight | Get Alert |
| 07/11/2023 | PRTA | Buy Now | Prothena Corp | $12.99 | 893.07% | Charles Duncan72% | → $129 | Reiterates | Overweight → Overweight | Get Alert |
| 06/28/2023 | PRTA | Buy Now | Prothena Corp | $12.99 | 893.07% | Charles Duncan72% | → $129 | Reiterates | Overweight → Overweight | Get Alert |
| 06/28/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Charles Duncan72% | → $110 | Reiterates | Overweight → Overweight | Get Alert |
| 06/28/2023 | CYBN | Buy Now | Cybin | $7.16 | -58.1% | Charles Duncan72% | → $114 | Reiterates | Overweight → Overweight | Get Alert |
| 06/23/2023 | MRNS | Buy Now | Marinus Pharma | — | — | Charles Duncan72% | $28 → $28 | Reiterates | Overweight → Overweight | Get Alert |
| 06/23/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $131.71 | -31.67% | Charles Duncan72% | $90 → $90 | Reiterates | Overweight → Overweight | Get Alert |
| 06/23/2023 | HRMY | Buy Now | Harmony Biosciences | $33.78 | 122.02% | Charles Duncan72% | $75 → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 06/23/2023 | SEEL | Buy Now | Seelos Therapeutics | $0.39 | 412.82% | Charles Duncan72% | → $7680 | Reiterates | Overweight → Overweight | Get Alert |
| 06/22/2023 | DNLI | Buy Now | Denali Therapeutics | $14.32 | 493.58% | Charles Duncan72% | → $85 | Reiterates | Overweight → Overweight | Get Alert |
| 06/22/2023 | CRNX | Buy Now | Crinetics Pharmaceuticals | $34.84 | 29.18% | Charles Duncan72% | → $45 | Reiterates | Overweight → Overweight | Get Alert |
| 06/22/2023 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | -14.21% | Charles Duncan72% | → $104 | Reiterates | Overweight → Overweight | Get Alert |
| 06/21/2023 | XENE | Buy Now | Xenon Pharmaceuticals | $34.77 | 66.81% | Charles Duncan72% | → $58 | Reiterates | Overweight → Overweight | Get Alert |
| 06/21/2023 | PRTA | Buy Now | Prothena Corp | $12.99 | 893.07% | Charles Duncan72% | → $129 | Reiterates | Overweight → Overweight | Get Alert |
| 06/21/2023 | CPRX | Buy Now | Catalyst Pharmaceuticals | $25.50 | -1.98% | Charles Duncan72% | → $25 | Reiterates | Overweight → Overweight | Get Alert |
| 05/23/2023 | STOK | Buy Now | Stoke Therapeutics | $8.26 | 202.66% | Charles Duncan72% | $20 → $25 | Maintains | Overweight | Get Alert |
| 05/18/2023 | MNMD | Buy Now | Mind Medicine | $6.75 | 3.78% | Charles Duncan72% | → $7 | Reiterates | → Overweight | Get Alert |
| 05/17/2023 | BIVI | Buy Now | BioVie | $1.11 | 890.99% | Charles Duncan72% | → $110 | Reiterates | Overweight → Overweight | Get Alert |
| 05/17/2023 | LUCD | Buy Now | Lucid Diagnostics | $1.52 | 163.16% | Charles Duncan72% | $4.5 → $4 | Maintains | Overweight | Get Alert |
| 05/16/2023 | CLNN | Buy Now | Clene | $3.62 | 10.5% | Charles Duncan72% | $100 → $80 | Maintains | Buy | Get Alert |
| 05/16/2023 | SEEL | Buy Now | Seelos Therapeutics | $0.39 | 412.82% | Charles Duncan72% | $11520 → $7680 | Maintains | Overweight | Get Alert |
| 05/09/2023 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | -14.21% | Charles Duncan72% | → $104 | Reiterates | → Overweight | Get Alert |
| 05/08/2023 | PRTA | Buy Now | Prothena Corp | $12.99 | 823.79% | Charles Duncan72% | $98 → $120 | Maintains | Overweight | Get Alert |
| 05/05/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $131.71 | -31.67% | Charles Duncan72% | $87 → $90 | Maintains | Overweight | Get Alert |
| 05/03/2023 | HRMY | Buy Now | Harmony Biosciences | $33.78 | 122.02% | Charles Duncan72% | $71 → $75 | Maintains | Overweight | Get Alert |
| 04/25/2023 | XENE | Buy Now | Xenon Pharmaceuticals | $34.77 | 66.81% | Charles Duncan72% | → $58 | Initiates | → Overweight | Get Alert |
| 04/04/2023 | BHVN | Buy Now | Biohaven | $29.88 | 3.75% | Charles Duncan72% | $27 → $31 | Maintains | Overweight | Get Alert |
| 04/03/2023 | CYTK | Buy Now | Cytokinetics | $44.01 | 34.06% | Charles Duncan72% | $61 → $59 | Maintains | Overweight | Get Alert |
| 03/29/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $131.71 | -33.94% | Charles Duncan72% | $83 → $87 | Maintains | Overweight | Get Alert |
| 03/27/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Charles Duncan72% | $121 → $138 | Maintains | Overweight | Get Alert |
| 03/14/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 93.72% | Charles Duncan72% | $28 → $33 | Maintains | Overweight | Get Alert |
| 03/10/2023 | KALV | Buy Now | KalVista Pharma | $12.21 | 170.27% | Charles Duncan72% | $49 → $33 | Maintains | Overweight | Get Alert |
| 03/10/2023 | CLNN | Buy Now | Clene | $3.62 | 120.99% | Charles Duncan72% | $120 → $160 | Maintains | Buy | Get Alert |
| 03/08/2023 | MRNS | Buy Now | Marinus Pharma | — | — | Charles Duncan72% | → $28 | Reiterates | → Overweight | Get Alert |
| 03/08/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | Charles Duncan72% | → $214 | Initiates | → Neutral | Get Alert |
| 03/07/2023 | CYTK | Buy Now | Cytokinetics | $44.01 | 38.6% | Charles Duncan72% | → $61 | Reiterates | → Overweight | Get Alert |
| 03/07/2023 | STOK | Buy Now | Stoke Therapeutics | $8.26 | 142.13% | Charles Duncan72% | → $20 | Reiterates | → Overweight | Get Alert |
| 03/01/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Charles Duncan72% | $61 → $121 | Maintains | Overweight | Get Alert |
| 02/07/2023 | NBIX | Buy Now | Neurocrine Biosciences | $115.10 | 10.34% | Charles Duncan72% | $132 → $127 | Reiterates | → Overweight | Get Alert |
| 02/01/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $131.71 | -36.98% | Charles Duncan72% | → $83 | Reiterates | → Overweight | Get Alert |
| 12/21/2022 | PRTA | Buy Now | Prothena Corp | $12.99 | 654.43% | Charles Duncan72% | $91 → $98 | Maintains | Overweight | Get Alert |
| 12/06/2022 | AVXL | Buy Now | Anavex Life Sciences | $9.65 | 14.02% | Charles Duncan72% | $16 → $11 | Downgrade | Overweight → Neutral | Get Alert |
| 11/22/2022 | FENC | Buy Now | Fennec Pharmaceuticals | $6.34 | 89.27% | Charles Duncan72% | $9 → $12 | Upgrade | Neutral → Overweight | Get Alert |
| 11/02/2022 | NBIX | Buy Now | Neurocrine Biosciences | $115.10 | 14.68% | Charles Duncan72% | $127 → $132 | Maintains | Overweight | Get Alert |
| 09/29/2022 | CGTX | Buy Now | Cognition Therapeutics | $0.45 | 2548.42% | Charles Duncan72% | → $12 | Initiates | → Overweight | Get Alert |
| 09/29/2022 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | Charles Duncan72% | → $41 | Initiates | → Overweight | Get Alert |
| 09/02/2022 | VXRT | Buy Now | Vaxart | $0.49 | 1526.68% | Charles Duncan72% | $11 → $8 | Maintains | Overweight | Get Alert |
| 07/22/2022 | BIVI | Buy Now | BioVie | $1.11 | 530.63% | Charles Duncan72% | → $70 | Initiates | → Overweight | Get Alert |
| 06/29/2022 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | -47.21% | Charles Duncan72% | $47 → $64 | Maintains | Overweight | Get Alert |
| 06/21/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 52.63% | Charles Duncan72% | $37 → $26 | Maintains | Overweight | Get Alert |
| 06/08/2022 | NVAX | Buy Now | Novavax | $7.70 | 2081.82% | Charles Duncan72% | $146 → $168 | Maintains | Overweight | Get Alert |
| 05/26/2022 | STOK | Buy Now | Stoke Therapeutics | $8.26 | 360.05% | Charles Duncan72% | $68 → $38 | Maintains | Overweight | Get Alert |
| 04/22/2022 | ITCI | Buy Now | Intra-Cellular Therapies | $131.71 | -55.2% | Charles Duncan72% | → $59 | Initiates | → Neutral | Get Alert |
| 04/14/2022 | HRMY | Buy Now | Harmony Biosciences | $33.78 | 86.5% | Charles Duncan72% | → $63 | Initiates | → Overweight | Get Alert |
| 04/11/2022 | CLNN | Buy Now | Clene | $3.62 | 176.24% | Charles Duncan72% | → $200 | Maintains | Overweight | Get Alert |
| 04/08/2022 | APTX | Buy Now | Aptinyx | — | — | Charles Duncan72% | $11 → $5 | Maintains | Overweight | Get Alert |
| 03/10/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 117.2% | Charles Duncan72% | $32 → $37 | Maintains | Overweight | Get Alert |
| 03/08/2022 | SEEL | Buy Now | Seelos Therapeutics | $0.39 | 669.23% | Charles Duncan72% | $19200 → $11520 | Maintains | Overweight | Get Alert |
| 02/18/2022 | ORMP | Buy Now | Oramed Pharmaceuticals | $2.43 | 723.05% | Charles Duncan72% | → $20 | Initiates | → Overweight | Get Alert |
| 02/18/2022 | VTVT | Buy Now | vTv Therapeutics | $16.70 | -70.06% | Charles Duncan72% | → $200 | Initiates | → Overweight | Get Alert |
| 01/10/2022 | BNOX | Buy Now | Bionomics | — | — | Charles Duncan72% | → $52 | Initiates | → Overweight | Get Alert |
| 12/17/2021 | CRDL | Buy Now | Cardiol Therapeutics | $1.16 | 589.66% | Charles Duncan72% | → $8 | Initiates | → Overweight | Get Alert |
| 12/09/2021 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Charles Duncan72% | $112 → $68 | Maintains | Overweight | Get Alert |
| 11/08/2021 | LUCD | Buy Now | Lucid Diagnostics | $1.52 | 1281.58% | Charles Duncan72% | → $21 | Initiates | → Overweight | Get Alert |
| 11/02/2021 | VXRT | Buy Now | Vaxart | $0.49 | 2950.02% | Charles Duncan72% | → $15 | Initiates | → Overweight | Get Alert |
| 09/17/2021 | PRTA | Buy Now | Prothena Corp | $12.99 | 692.92% | Charles Duncan72% | $70 → $103 | Maintains | Overweight | Get Alert |
| 09/13/2021 | BHVN | Buy Now | Biohaven | $29.88 | 452.21% | Charles Duncan72% | $151 → $165 | Maintains | Overweight | Get Alert |
| 08/26/2021 | CYBN | Buy Now | Cybin | $7.16 | 25.7% | Charles Duncan72% | → $342 | Initiates | → Overweight | Get Alert |
| 07/13/2021 | ATAI | Buy Now | ATAI Life Sciences | $1.66 | 2611.82% | Charles Duncan72% | → $45 | Initiates | → Overweight | Get Alert |
| 06/15/2021 | NVAX | Buy Now | Novavax | $7.70 | 3432.47% | Charles Duncan72% | $217 → $272 | Maintains | Overweight | Get Alert |
| 06/01/2021 | SEEL | Buy Now | Seelos Therapeutics | $0.39 | 2464.1% | Charles Duncan72% | → $38400 | Initiates | → Overweight | Get Alert |
| 06/01/2021 | BHVN | Buy Now | Biohaven | $29.88 | 368.54% | Charles Duncan72% | $125 → $140 | Maintains | Overweight | Get Alert |
| 05/12/2021 | NVAX | Buy Now | Novavax | $7.70 | 2718.18% | Charles Duncan72% | $338 → $217 | Maintains | Overweight | Get Alert |
| 05/03/2021 | CLNN | Buy Now | Clene | $3.62 | 507.73% | Charles Duncan72% | → $440 | Initiates | → Overweight | Get Alert |
| 04/20/2021 | OVID | Buy Now | Ovid Therapeutics | $0.44 | 818.48% | Charles Duncan72% | $8 → $4 | Downgrade | Overweight → Neutral | Get Alert |
| 02/23/2021 | AVXL | Buy Now | Anavex Life Sciences | $9.65 | 159.13% | Charles Duncan72% | $10 → $25 | Reiterates | → Overweight | Get Alert |
| 02/05/2021 | NVAX | Buy Now | Novavax | $7.70 | 4289.61% | Charles Duncan72% | $248 → $338 | Maintains | Overweight | Get Alert |
| 12/03/2020 | LUMO | Buy Now | Lumos Pharma | — | — | Charles Duncan72% | → $32 | Initiates | → Overweight | Get Alert |
| 10/28/2020 | APTX | Buy Now | Aptinyx | — | — | Charles Duncan72% | $9 → $12 | Maintains | Overweight | Get Alert |
| 10/23/2020 | STOK | Buy Now | Stoke Therapeutics | $8.26 | 493.22% | Charles Duncan72% | → $49 | Initiates | → Overweight | Get Alert |
| 10/23/2020 | SAVA | Buy Now | Cassava Sciences | $1.89 | 1173.21% | Charles Duncan72% | → $24 | Initiates | → Overweight | Get Alert |
| 10/21/2020 | PRTA | Buy Now | Prothena Corp | $12.99 | 84.76% | Charles Duncan72% | $20 → $24 | Maintains | Overweight | Get Alert |
| 09/28/2020 | INO | Buy Now | Inovio Pharmaceuticals | $1.80 | 566.67% | Charles Duncan72% | $372 → $144 | Downgrade | Overweight → Neutral | Get Alert |
| 09/11/2020 | PRVL | Buy Now | Prevail Therapeutics | — | — | Charles Duncan72% | → $26 | Initiates | → Overweight | Get Alert |
| 09/01/2020 | AIMT | Buy Now | Aimmune Therapeutics | — | — | Charles Duncan72% | $24 → $35 | Downgrade | Overweight → Neutral | Get Alert |
| 07/21/2020 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 258.09% | Charles Duncan72% | $63 → $61 | Maintains | Overweight | Get Alert |
| 06/26/2020 | INO | Buy Now | Inovio Pharmaceuticals | $1.80 | 2400% | Charles Duncan72% | $204 → $540 | Maintains | Overweight | Get Alert |
| 06/19/2020 | NVAX | Buy Now | Novavax | $7.70 | 1042.86% | Charles Duncan72% | $45 → $88 | Maintains | Overweight | Get Alert |
| 06/18/2020 | OVID | Buy Now | Ovid Therapeutics | $0.44 | 2885.07% | Charles Duncan72% | $7 → $13 | Maintains | Overweight | Get Alert |
| 06/05/2020 | FENC | Buy Now | Fennec Pharmaceuticals | $6.34 | 183.91% | Charles Duncan72% | → $18 | Initiates | → Overweight | Get Alert |
| 06/01/2020 | GERN | Buy Now | Geron | $1.68 | 138.81% | Charles Duncan72% | $3 → $4 | Maintains | Overweight | Get Alert |
| 05/19/2020 | CARA | Buy Now | Cara Therapeutics | $5.42 | 638.69% | Charles Duncan72% | $408 → $480 | Reiterates | → Overweight | Get Alert |
| 05/18/2020 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Charles Duncan72% | $270 → $275 | Maintains | Overweight | Get Alert |
| 05/11/2020 | BHVN | Buy Now | Biohaven | $29.88 | 174.43% | Charles Duncan72% | $75 → $82 | Maintains | Overweight | Get Alert |
| 05/08/2020 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 269.83% | Charles Duncan72% | $58 → $63 | Reiterates | → Overweight | Get Alert |
| 05/04/2020 | HALO | Buy Now | Halozyme Therapeutics | $64.26 | -39.31% | Charles Duncan72% | $35 → $39 | Reiterates | → Overweight | Get Alert |
| 04/28/2020 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | 8.06% | Charles Duncan72% | $125 → $131 | Maintains | Overweight | Get Alert |
| 04/22/2020 | CARA | Buy Now | Cara Therapeutics | $5.42 | 527.89% | Charles Duncan72% | $312 → $408 | Reiterates | → Overweight | Get Alert |
| 04/17/2020 | CYTK | Buy Now | Cytokinetics | $44.01 | -47.74% | Charles Duncan72% | $12 → $23 | Reiterates | → Overweight | Get Alert |
| 04/15/2020 | INO | Buy Now | Inovio Pharmaceuticals | $1.80 | 622.22% | Charles Duncan72% | $144 → $156 | Maintains | Overweight | Get Alert |
| 03/23/2020 | AIMT | Buy Now | Aimmune Therapeutics | — | — | Charles Duncan72% | $64 → $32 | Maintains | Overweight | Get Alert |
| 03/17/2020 | NVAX | Buy Now | Novavax | $7.70 | 107.79% | Charles Duncan72% | $6 → $16 | Upgrade | Neutral → Overweight | Get Alert |
| 02/27/2020 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 340.27% | Charles Duncan72% | $70 → $75 | Reiterates | → Overweight | Get Alert |
| 02/21/2020 | CORT | Buy Now | Corcept Therapeutics | $58.23 | -74.24% | Charles Duncan72% | $14 → $15 | Reiterates | → Neutral | Get Alert |
| 02/20/2020 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Charles Duncan72% | $314 → $320 | Reiterates | → Overweight | Get Alert |
| 02/18/2020 | ITCI | Buy Now | Intra-Cellular Therapies | $131.71 | -64.31% | Charles Duncan72% | $43 → $47 | Reiterates | → Overweight | Get Alert |
| 02/14/2020 | CPRX | Buy Now | Catalyst Pharmaceuticals | $25.50 | -52.95% | Charles Duncan72% | $11 → $12 | Reiterates | → Overweight | Get Alert |
| 02/03/2020 | AIMT | Buy Now | Aimmune Therapeutics | — | — | Charles Duncan72% | $55 → $64 | Maintains | Overweight | Get Alert |
| 01/27/2020 | HALO | Buy Now | Halozyme Therapeutics | $64.26 | -45.53% | Charles Duncan72% | $27 → $35 | Maintains | Overweight | Get Alert |
| 12/30/2019 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | 3.11% | Charles Duncan72% | $104 → $125 | Reiterates | → Overweight | Get Alert |
| 12/17/2019 | ADMS | Buy Now | Adamas Pharmaceuticals | — | — | Charles Duncan72% | $8 → $7 | Reiterates | → Neutral | Get Alert |
| 12/16/2019 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | -14.21% | Charles Duncan72% | $55 → $104 | Maintains | Overweight | Get Alert |
| 11/26/2019 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 310.92% | Charles Duncan72% | $63 → $70 | Reiterates | → Overweight | Get Alert |
| 11/20/2019 | HALO | Buy Now | Halozyme Therapeutics | $64.26 | -57.98% | Charles Duncan72% | $26 → $27 | Reiterates | → Overweight | Get Alert |
| 11/20/2019 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Charles Duncan72% | $250 → $314 | Reiterates | → Overweight | Get Alert |
| 11/04/2019 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Charles Duncan72% | $180 → $250 | Maintains | Overweight | Get Alert |
| 10/15/2019 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Charles Duncan72% | $125 → $180 | Maintains | Overweight | Get Alert |
| 09/23/2019 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 228.73% | Charles Duncan72% | $49 → $56 | Maintains | Overweight | Get Alert |
| 09/09/2019 | ADMS | Buy Now | Adamas Pharmaceuticals | — | — | Charles Duncan72% | → $8 | Initiates | → Neutral | Get Alert |
| 08/27/2019 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 134.81% | Charles Duncan72% | $30 → $40 | Reiterates | → Overweight | Get Alert |
| 08/15/2019 | GERN | Buy Now | Geron | $1.68 | 138.81% | Charles Duncan72% | → $4 | Initiates | → Overweight | Get Alert |
| 03/26/2019 | INO | Buy Now | Inovio Pharmaceuticals | $1.80 | — | Charles Duncan72% | — | Initiates | → Overweight | Get Alert |
| 03/22/2019 | APTX | Buy Now | Aptinyx | — | — | Charles Duncan72% | $18 → $12 | Maintains | Overweight | Get Alert |
| 03/21/2019 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | -79.38% | Charles Duncan72% | $16 → $25 | Maintains | Overweight | Get Alert |
| 02/06/2019 | VNDA | Buy Now | Vanda Pharma | $4.78 | — | Charles Duncan72% | — | Downgrade | Overweight → Neutral | Get Alert |
| 02/01/2019 | CORT | Buy Now | Corcept Therapeutics | $58.23 | -75.96% | Charles Duncan72% | $20 → $14 | Downgrade | Overweight → Neutral | Get Alert |
| 12/12/2018 | CORT | Buy Now | Corcept Therapeutics | $58.23 | -50.2% | Charles Duncan72% | $17 → $29 | Upgrade | Neutral → Overweight | Get Alert |
| 12/04/2018 | VNDA | Buy Now | Vanda Pharma | $4.78 | 800.52% | Charles Duncan72% | → $43 | Upgrade | Neutral → Overweight | Get Alert |
| 11/29/2018 | CPRX | Buy Now | Catalyst Pharmaceuticals | $25.50 | -68.63% | Charles Duncan72% | → $8 | Reiterates | → Overweight | Get Alert |
| 11/15/2018 | OVID | Buy Now | Ovid Therapeutics | $0.44 | — | Charles Duncan72% | — | Initiates | → Overweight | Get Alert |
| 11/15/2018 | BHVN | Buy Now | Biohaven | $29.88 | 84.07% | Charles Duncan72% | $57 → $55 | Maintains | Overweight | Get Alert |
| 11/15/2018 | AXSM | Buy Now | Axsome Therapeutics | $121.23 | -86.8% | Charles Duncan72% | → $16 | Reinstates | → Overweight | Get Alert |
| 11/15/2018 | APTX | Buy Now | Aptinyx | — | — | Charles Duncan72% | → $40 | Initiates | → Overweight | Get Alert |
| 11/01/2018 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 76.11% | Charles Duncan72% | $27 → $30 | Maintains | Overweight | Get Alert |
| 10/16/2018 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 58.5% | Charles Duncan72% | $25 → $27 | Maintains | Overweight | Get Alert |
| 09/21/2018 | CPRX | Buy Now | Catalyst Pharmaceuticals | $25.50 | -68.63% | Charles Duncan72% | → $8 | Initiates | → Overweight | Get Alert |
| 09/21/2018 | CARA | Buy Now | Cara Therapeutics | $5.42 | 398.61% | Charles Duncan72% | → $324 | Initiates | → Overweight | Get Alert |
| 08/23/2018 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Charles Duncan72% | → $90 | Initiates | → Overweight | Get Alert |
| 08/23/2018 | VNDA | Buy Now | Vanda Pharma | $4.78 | 444.5% | Charles Duncan72% | → $26 | Initiates | → Neutral | Get Alert |
| 08/23/2018 | ITCI | Buy Now | Intra-Cellular Therapies | $131.71 | -75.7% | Charles Duncan72% | → $32 | Initiates | → Overweight | Get Alert |
| 08/23/2018 | CORT | Buy Now | Corcept Therapeutics | $58.23 | -70.81% | Charles Duncan72% | → $17 | Initiates | → Neutral | Get Alert |
| 08/23/2018 | HALO | Buy Now | Halozyme Therapeutics | $64.26 | -57.98% | Charles Duncan72% | → $27 | Initiates | → Overweight | Get Alert |
| 08/23/2018 | BHVN | Buy Now | Biohaven | $29.88 | 84.07% | Charles Duncan72% | → $55 | Initiates | → Overweight | Get Alert |
| 08/23/2018 | ACOR | Buy Now | Acorda Therapeutics | — | — | Charles Duncan72% | → $3840 | Initiates | → Neutral | Get Alert |
| 08/23/2018 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 46.76% | Charles Duncan72% | → $25 | Initiates | → Overweight | Get Alert |
| 06/12/2018 | BHVN | Buy Now | Biohaven | $29.88 | 40.56% | Charles Duncan72% | → $42 | Initiates | → Overweight | Get Alert |
| 04/10/2018 | VTVT | Buy Now | vTv Therapeutics | $16.70 | — | Charles Duncan72% | — | Downgrade | Overweight → Neutral | Get Alert |
| 11/15/2017 | SGMO | Buy Now | Sangamo Therapeutics | $0.84 | — | Charles Duncan72% | — | Upgrade | Neutral → Overweight | Get Alert |
| 10/09/2017 | ALT | Buy Now | Altimmune | $5.91 | 1.61% | Charles Duncan72% | → $180 | Initiates | → Overweight | Get Alert |
| 09/29/2017 | ZYNE | Buy Now | Zynerba Pharmaceuticals | — | — | Charles Duncan72% | — | Upgrade | Neutral → Overweight | Get Alert |
| 06/08/2017 | INO | Buy Now | Inovio Pharmaceuticals | $1.80 | — | Charles Duncan72% | — | Upgrade | Neutral → Overweight | Get Alert |
| 05/01/2017 | ITCI | Buy Now | Intra-Cellular Therapies | $131.71 | -92.41% | Charles Duncan72% | $22 → $10 | Downgrade | Overweight → Neutral | Get Alert |
| 03/16/2017 | INO | Buy Now | Inovio Pharmaceuticals | $1.80 | 400% | Charles Duncan72% | $156 → $108 | Downgrade | Overweight → Neutral | Get Alert |
| 12/22/2016 | PDLI | Buy Now | PDL BioPharma | — | — | Charles Duncan72% | → $4 | Reinstates | → Overweight | Get Alert |
| 12/16/2016 | ITCI | Buy Now | Intra-Cellular Therapies | $131.71 | — | Charles Duncan72% | — | Initiates | → Overweight | Get Alert |
| 10/19/2016 | SGMO | Buy Now | Sangamo Therapeutics | $0.84 | — | Charles Duncan72% | — | Downgrade | Overweight → Neutral | Get Alert |
| 06/02/2016 | ITCI | Buy Now | Intra-Cellular Therapies | $131.71 | -56.72% | Charles Duncan72% | → $57 | Initiates | → Overweight | Get Alert |
| 06/01/2016 | ITCI | Buy Now | Intra-Cellular Therapies | $131.71 | -56.72% | Charles Duncan72% | → $57 | Initiates | → Overweight | Get Alert |
| 11/04/2015 | CARA | Buy Now | Cara Therapeutics | $5.42 | — | Charles Duncan72% | — | Initiates | → Buy | Get Alert |
| 08/31/2015 | ZYNE | Buy Now | Zynerba Pharmaceuticals | — | — | Charles Duncan72% | → $42 | Initiates | → Overweight | Get Alert |
| 08/24/2015 | VTVT | Buy Now | vTv Therapeutics | $16.70 | 43.71% | Charles Duncan72% | → $960 | Initiates | → Overweight | Get Alert |
| 05/14/2013 | PDLI | Buy Now | PDL BioPharma | — | — | Charles Duncan72% | → $8.5 | Initiates | → Neutral | Get Alert |
| 07/02/2012 | SGMO | Buy Now | Sangamo Therapeutics | $0.84 | 377.78% | Charles Duncan72% | → $4 | Downgrade | Neutral → Underweight | Get Alert |
